Share Twitter LinkedIn Facebook Email Michael Wang, M.D. Professor in the department of Lymphoma & Myeloma at MD Anderson Discusses Acalabrutinib Trial follow Up At The 60th ASH Annual Meeting on Dec 1, 2018.
2024 Update on Lymphoma Treatment: Navigating the Latest Advances – Elizabeth Brem, MD [38 Slides] Hodgkin Lymphoma 4 Mins Read
FDA Grants Accelerated Approval to Zanubrutinib (Brukinsa) for Relapsed or Refractory Follicular Lymphoma Lymphoma 2 Mins Read
FDA Grants Priority Review of Epcoritamab (EPKINLY): A Significant Step in Lymphoma Treatment [VIDEO EXCLUSIVE] Lymphoma 3 Mins Read
